NOBLE is a clinical study to evaluate an investigational drug for patients with mild to moderate Alzheimer’s disease. Participants will receive the study drug or a placebo. During this study, if you are already taking medication for Alzheimer’s disease, you will probably continue to take it along with the study drug or placebo. The investigational drug may work by protecting brain cells which could result in improved memory. But, this has not been proven yet. We are doing this study to find out if this is true.
The study will enroll 450 patients with mild to moderate Alzheimer’s disease at many research sites across the United States. Total participation time is about 14 months, which includes screening, about one year of study treatment, and follow up to check safety.